Our results increase our understanding of the mechanisms through which the COX-2/EP1R/MAPK/E2F-1 pathways regulate β1-integrin expression and cancer invasion, and may guide the future development of therapeutic interventions. The gene discussed is PTGS2; the disease is cancer.